Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
FEB 25, 2025 | 8:00 AM
C.E. CREDITS
Dr. Berger’s session will explore the development of MSK-IMPACT and MSK-ACCESS, MSK’s comprehensive genomic profiling and cfDNA analysis programs. These initiatives address the n...
FEB 04, 2025 | 10:00 AM
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
DEC 04, 2024 | 8:30 AM
Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated exp...
NOV 19, 2024 | 8:00 AM
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
NOV 14, 2024 | 12:00 PM
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adver...
NOV 14, 2024 | 12:00 PM
C.E. CREDITS
Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often mask...
NOV 13, 2024 | 10:00 AM
Brain tumors are the leading cause of solid-tumor-related deaths among children. These tumors are now categorized by WHO as separated from adult brain tumors and based on their distinct mole...
NOV 13, 2024 | 8:00 AM
While a decade ago the prognosis of lung cancer patients was very disappointing, nowadays a substantial evolution is driven by targeted treatments and immuno-oncology. With extended, scaled...
NOV 07, 2024 | 8:00 AM
High resolution surveys of the tumor microenvironment (TME) are needed to obtain a holistic portrait of the genetic, epigenetic, and cellular factors contributing to cancer progression. To t...
OCT 31, 2024 | 8:00 AM
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
OCT 29, 2024 | 2:30 PM
Antibody–drug conjugates (ADC) are targeted therapies that are designed to deliver highly potent cytotoxic agents to specific tumor cells saving normal tissue. They combined a monoclon...
On Demand
C.E. CREDITS
The path from research discovery to effective immune cell therapies requires innovative approaches to match the challenges we face. Examining the full richness of biological complexity&mdash...
October 15, 2024 | 7:00am PDT, 9:00am CDT, 10:00am EDT
Advancements in spatial proteomic workflows, featuring enzyme-activated spatial amplification reagents, have revolutionized cancer research capabilities. This webinar will include an explana...
OCT 02, 2024 | 11:00 AM
Genomic analysis of cancer cells revealed comprehensive mechanism of tumorigenesis in human patients. Among the abnormalities discovered so far, CNVs accounted for a great portion of all the...
OCT 02, 2024 | 8:00 AM
In this webinar, discover how Dr El Ahmar utilizes the BOND RX autostainer and image analysis workflow to stain formalin-fixed paraffin-embedded (FFPE) clinical trial samples with multiplex...
On Demand
C.E. CREDITS
Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkp...
On Demand
C.E. CREDITS
Pancreatic ductal adenocarcinoma (PDAC) is characterized clinically by poor survival and mechanistically by KRAS- and autophagy-dependent growth. We and others previously demonstrated that i...
